المؤلفون: Challagulla, S., Lee, P., Kistler, K., Douyon, L., Lai, D., Iyengar, R.

المصدر: Value in Health ; volume 24, page S38 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2021.04.193
https://api.elsevier.com/content/article/PII:S1098301521004101?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301521004101?httpAccept=text/plain

المؤلفون: Cadarette, S.M., Douyon, L, Ranganathan, P, Ballew, N, Colby, JA, Maiese, B.A., Slaff, S, Wissinger, E, Ruiz, K

المصدر: Value in Health ; volume 21, page S402 ; ISSN 1098-3015

الاتاحة: http://dx.doi.org/10.1016/j.jval.2018.09.2908
https://api.elsevier.com/content/article/PII:S1098301518362831?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1098301518362831?httpAccept=text/plain

المؤلفون: Ceppi, F, Gagné, V, Douyon, L, Quintin, C, Colombini, A, Parasole, R, Buldini, B, Basso, G, Conter, V, Cazzaniga, G, Krajinovic, M, Ceppi, Francesco, Gagné, Vincent, Douyon, Laurance, Quintin, Camille J., Colombini, Antonella, Parasole, Rosanna, Buldini, Barbara, Basso, Giuseppe, Conter, Valentino, Cazzaniga, Giovanni, Krajinovic, Maja

مصطلحات الفهرس: childhood ALL, dihydrofolate reductase polymorphism, treatment outcome, MED/03 - GENETICA MEDICA, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10281/226356
http://www.futuremedicine.com/loi/pgs?cookieSet=1
info:eu-repo/semantics/altIdentifier/pmid/29210328
info:eu-repo/semantics/altIdentifier/wos/WOS:000428950200004
volume:19
issue:2
firstpage:105
lastpage:112
numberofpages:8
journal:PHARMACOGENOMICS

المؤلفون: Wittkower, E. D., Douyon, L., Bijou, L.

المصدر: Acta Psychotherapeutica et Psychosomatica, 1964 Jan 01. 12(1), 72-80.

URL الوصول: https://www.jstor.org/stable/45107385

المؤلفون: Ceppi, F., Gagné, V., Douyon, L., Quintin, C.J., Colombini, A., Parasole, R., Buldini, B., Basso, G., Conter, V., Cazzaniga, G., Krajinovic, M.

المصدر: Pharmacogenomics, vol. 19, no. 2, pp. 105-112

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Asparaginase/therapeutic use, Biomarkers, Tumor/genetics, Child, DNA/genetics, Daunorubicin/therapeutic use, Disease-Free Survival, Female, Haplotypes/genetics, Humans, Male, Methotrexate/therapeutic use, Polymorphism, Genetic/genetics, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics, Prednisone/therapeutic use, Promoter Regions, Tetrahydrofolate Dehydrogenase/genetics, Treatment Outcome, Vincristine/therapeutic use, childhood ALL, dihydrofolate reductase polymorphisms

Relation: info:eu-repo/semantics/altIdentifier/pmid/29210328; info:eu-repo/semantics/altIdentifier/eissn/1744-8042; https://serval.unil.ch/notice/serval:BIB_CE42BB1FCCE7; urn:issn:1462-2416

الاتاحة: https://serval.unil.ch/notice/serval:BIB_CE42BB1FCCE7
https://doi.org/10.2217/pgs-2017-0153

المؤلفون: NOE, E. A., SANDERS, T., BADELLE, F., DOUYON, L.

المصدر: Chemischer Informationsdienst ; volume 14, issue 50 ; ISSN 0009-2975 2199-2924

الاتاحة: http://dx.doi.org/10.1002/chin.198350049
http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.198350049
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.198350049
https://onlinelibrary.wiley.com/doi/pdf/10.1002/chin.198350049

المؤلفون: Maja Krajinovic, Laurance Douyon, Vincent Gagné, Barbara Buldini, Camille J Quintin, Giovanni Cazzaniga, Giuseppe Basso, Francesco Ceppi, Rosanna Parasole, Antonella Colombini, Valentino Conter

المساهمون: Ceppi, F, Gagné, V, Douyon, L, Quintin, C, Colombini, A, Parasole, R, Buldini, B, Basso, G, Conter, V, Cazzaniga, G, Krajinovic, M

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, MED/03 - GENETICA MEDICA, chemistry.chemical_compound, 0302 clinical medicine, Dihydrofolate reductase, Genotype, Antineoplastic Combined Chemotherapy Protocols, Child, Promoter Regions, Genetic, dihydrofolate reductase polymorphisms, Tumor, biology, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Vincristine, 030220 oncology & carcinogenesis, Molecular Medicine, Biomarker (medicine), Female, medicine.drug, medicine.medical_specialty, Asparaginase, dihydrofolate reductase polymorphism, childhood ALL, treatment outcome, Biomarkers, Tumor, DNA, Daunorubicin, Disease-Free Survival, Haplotypes, Humans, Methotrexate, Polymorphism, Genetic, Prednisone, Tetrahydrofolate Dehydrogenase, Treatment Outcome, Genetics, Pharmacology, Promoter Regions, 03 medical and health sciences, Genetic, Internal medicine, medicine, Polymorphism, Childhood Acute Lymphoblastic Leukemia, business.industry, Haplotype, 030104 developmental biology, chemistry, biology.protein, business, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::752449b810e2134f650df07bba094b14
http://hdl.handle.net/10281/226356